Product Safety Recalls

Product Recall Tracker

Recall D-1349-2022

Description: Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56

Recall D-1349-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1349-2022
Event ID90677
DistributionNationwide within the USA
Quantity4,160 vials
Recall ReasonSubpotent Drug
Drug ClassificationClass III
Drug Code Info20220824
Recall Initiation Date20220727
Report Date20220824
Classification Date20220817
Address2550 John Glenn Ave Ste A
Columbus, OH 43217-1188
United States
Recalling FirmAmerisource Health Services LLC
Initial Notification Letter
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.